SG11202003539VA - Compositions and methods for treating liberibacter diseases and other bacterial diseases - Google Patents

Compositions and methods for treating liberibacter diseases and other bacterial diseases

Info

Publication number
SG11202003539VA
SG11202003539VA SG11202003539VA SG11202003539VA SG11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA SG 11202003539V A SG11202003539V A SG 11202003539VA
Authority
SG
Singapore
Prior art keywords
diseases
liberibacter
compositions
treating
methods
Prior art date
Application number
SG11202003539VA
Inventor
Hailing Jin
Chien Yu Huang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SG11202003539VA publication Critical patent/SG11202003539VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Virology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202003539VA 2017-10-23 2018-10-23 Compositions and methods for treating liberibacter diseases and other bacterial diseases SG11202003539VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762575993P 2017-10-23 2017-10-23
US201862677817P 2018-05-30 2018-05-30
PCT/US2018/057153 WO2019084040A1 (en) 2017-10-23 2018-10-23 Compositions and methods for treating liberibacter diseases and other bacterial diseases

Publications (1)

Publication Number Publication Date
SG11202003539VA true SG11202003539VA (en) 2020-05-28

Family

ID=66247003

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003539VA SG11202003539VA (en) 2017-10-23 2018-10-23 Compositions and methods for treating liberibacter diseases and other bacterial diseases

Country Status (7)

Country Link
US (2) US11963533B2 (en)
EP (1) EP3700547A4 (en)
CN (1) CN111246875B (en)
BR (1) BR112020007108A2 (en)
MX (1) MX2020004118A (en)
SG (1) SG11202003539VA (en)
WO (1) WO2019084040A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022004320A (en) * 2019-10-11 2022-05-11 Univ California Compositions and methods for treating liberibacter diseases and other bacterial diseases.
US11518694B2 (en) * 2019-12-18 2022-12-06 Maxwell Zachary Price Methods of inhibiting cyanobacteria using citron
CN111748555A (en) * 2020-07-22 2020-10-09 西南大学 sgRNA for improving citrus and application and use method thereof
WO2022174232A2 (en) * 2021-02-09 2022-08-18 The Regents Of The University Of California Immune regulators involved in defense against plant diseases caused by liberibacter species
CN114350702A (en) * 2022-01-27 2022-04-15 浙江农林大学 Virus inoculation method for citrus
CN116715733A (en) * 2022-10-18 2023-09-08 深圳润康生态环境股份有限公司 Antibacterial peptide STJ-2 for effectively inhibiting proliferation of citrus yellow dragon disease pathogenic bacteria and application thereof
CN118666972A (en) * 2023-03-14 2024-09-20 中国科学院微生物研究所 Antibacterial peptide and application thereof in preventing and treating citrus yellow dragon disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2806731A4 (en) 2012-01-27 2015-09-23 Texas A & M Univ Sys Pathogen resistant citrus compositions, organisms, systems, and methods
MX2013004623A (en) * 2013-04-24 2014-10-24 Ct Investig Y Estudios Del Ipn Methods for obtaining genetically modified plants resistant to pathogenic microorganisms growing in vascular tissues.
WO2017011815A2 (en) * 2015-07-15 2017-01-19 Texas A&M University Citrus plants resistant to citrus huanglongbing (ex greening) caused by candidatus liberibacter asiaticus (las) and bacterial canker caused by (xanthomonas axonopodis pv. citri) (xac) using spinach defensin genes in ctv vectors
WO2017011796A1 (en) * 2015-07-15 2017-01-19 The Texas A&M University System Pathogen resistant citrus compositions, organisms, systems, and methods
CN106337059A (en) * 2016-09-12 2017-01-18 西南大学 Method for improving citrus huanglongbing resistance

Also Published As

Publication number Publication date
EP3700547A4 (en) 2021-10-27
MX2020004118A (en) 2020-07-29
US20210186028A1 (en) 2021-06-24
US11963533B2 (en) 2024-04-23
WO2019084040A1 (en) 2019-05-02
EP3700547A1 (en) 2020-09-02
BR112020007108A2 (en) 2020-10-13
CN111246875A (en) 2020-06-05
US20240306649A1 (en) 2024-09-19
CN111246875B (en) 2024-01-30

Similar Documents

Publication Publication Date Title
EP3634442A4 (en) Methods for treating and preventing diseases
IL273959A (en) Methods and compositions for the treatment of rare diseases
SG11202003539VA (en) Compositions and methods for treating liberibacter diseases and other bacterial diseases
EP3319976A4 (en) Compositions and methods for treating lung diseases and lung injury
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
IL269158A (en) Compositions and methods for treating inflammatory diseases
IL274702A (en) Compositions and methods for neurological diseases
EP3139928A4 (en) Anordrin compositions and methods for treating diseases
EP3310385A4 (en) Methods and compositions for treating fibrotic diseases
EP3110446A4 (en) Methods and compositions for treating siglec-8 associated diseases
IL280413A (en) Bismuth-thiol compositions and methods for treating wounds
EP3268010A4 (en) Compositions and methods for treating bacterial infection
EP3634431A4 (en) Therapeutic compositions and methods for treating hepatitis b
IL275767A (en) Compositions and methods for treating metabolic diseases
EP3634422A4 (en) Methods of treating leukodystrophies
EP3600291A4 (en) Compositions and methods for treating synucleinopathies
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
EP3411367A4 (en) Compositions and methods for treating infections
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
DK3630111T3 (en) Compounds and methods for treating bacterial infections
EP3823593A4 (en) Compositions and methods for treating autism
PL3810128T3 (en) Compositions for treating and/or preventing protein-aggregation diseases
EP3672583A4 (en) Compositions and methods for treating neurodegenerative diseases
EP3658118A4 (en) Methods and compositions for treating respiratory disease